Roth Capital Partners (Roth) has become aware that there are individuals on WhatsApp and possibly other social media outlets who are falsely impersonating employees or people connected with this firm. Please be aware that any such messages are not authorized by Roth and are apparently being used to perpetrate illegitimate activity. For more information please visit – Here
| James Antonopoulos is a Managing Director and Head of Healthcare Investment Banking at ROTH. Before joining Roth Capital Partners, he was a Senior Investment Banker at Canaccord Genuity Inc. James has over 10 years of investment banking experience and completed over 300 equity, debt, and M&A transactions, representing over $12.0 billion in aggregate value. Mr. Antonopoulos has advised and raised capital for a wide range of Healthcare companies and has served on multiple Boards, including MabVax Therapeutics Holdings, Inc. and Bella Financial Investments LLC. Before joining Canaccord, he was in the Investment Banking Group at Rodman & Renshaw. Mr. Antonopoulos received his B.S. from Babson College and J.D. from Villanova School of Law, where he was on the Villanova Law Review. |
June 2017
Healthcare
B.S. from Babson College; J.D. from Villanova School of Law
Canaccord Genuity Inc.; Rodman & Renshaw
